dactinomycin has been researched along with Parkinson Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barzilai, A; Melamed, E; Offen, D; Shirvan, A; Zilkha-Falb, R; Ziv, I | 1 |
Jimenez Del Rio, M; Velez-Pardo, C | 1 |
2 other study(ies) available for dactinomycin and Parkinson Disease
Article | Year |
---|---|
Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?
Topics: Animals; Antioxidants; Antiparkinson Agents; Apoptosis; Cell Count; Cell Survival; Cells, Cultured; Chick Embryo; Corpus Striatum; Cycloheximide; Dactinomycin; Flow Cytometry; Ganglia, Sympathetic; Humans; Levodopa; Microscopy, Fluorescence; Nerve Degeneration; Neurons; Parkinson Disease; Substantia Nigra | 1997 |
17 beta-estradiol protects lymphocytes against dopamine and iron-induced apoptosis by a genomic-independent mechanism. Implication in Parkinson's disease.
Topics: Adult; Apoptosis; Cycloheximide; Dactinomycin; DNA Fragmentation; Dopamine; Electrophoresis, Agar Gel; Estradiol; Genomics; Humans; Hydrogen Peroxide; Iron; Lymphocytes; Male; Parkinson Disease; Predictive Value of Tests; Protein Synthesis Inhibitors; Receptors, Estrogen | 2000 |